Epidermolysis Bullosa
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Our study expands the phenotypic spectrum of COL17A1 disease from autosomal recessive epidermolysis bullosa to autosomal dominant ERED and identifies COL17A1 as a key protein in maintaining integrity of the corneal epithelium.
|
26786512 |
2016 |
Epidermolysis Bullosa
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Despite the high incidence of revertant mosaicism (35%) in patients with the genetic skin disease epidermolysis bullosa (EB) due to correcting mutations in the genes COL17A1 and LAMB3, revertant mosaicism has not been described for COL7A1 until recently.
|
20574443 |
2010 |
Epidermolysis Bullosa
|
0.100 |
Biomarker
|
disease |
BEFREE |
This model shows fidelity to alterations seen in patients with BP, has relevance to immune responses that may arise in patients with epidermolysis bullosa following BPAG2 gene replacement, and can be used to identify interventions that may block production of IgG against proteins in epidermal BM.
|
17657247 |
2007 |
Epidermolysis Bullosa
|
0.100 |
Biomarker
|
disease |
LHGDN |
This model shows fidelity to alterations seen in patients with BP, has relevance to immune responses that may arise in patients with epidermolysis bullosa following BPAG2 gene replacement, and can be used to identify interventions that may block production of IgG against proteins in epidermal BM.
|
17657247 |
2007 |
Epidermolysis Bullosa
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Revertant mosaicism due to in vivo reversion of an inherited mutation has been described in the genetic skin disease epidermolysis bullosa (EB) for the genes KRT14 and COL17A1.
|
17476356 |
2007 |
Epidermolysis Bullosa
|
0.100 |
GeneticVariation
|
disease |
LHGDN |
Protein structural analysis of BP180 mutant isoforms linked to non-Herlitz junctional epidermolysis bullosa.
|
16417243 |
2006 |
Epidermolysis Bullosa
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Multiple correcting COL17A1 mutations in patients with revertant mosaicism of epidermolysis bullosa.
|
16252234 |
2005 |
Epidermolysis Bullosa
|
0.100 |
GeneticVariation
|
disease |
LHGDN |
Molecular mechanisms of junctional epidermolysis bullosa: Col 15 domain mutations decrease the thermal stability of collagen XVII.
|
16354180 |
2005 |
Epidermolysis Bullosa
|
0.100 |
AlteredExpression
|
disease |
LHGDN |
A very mild form of non-Herlitz junctional epidermolysis bullosa: BP180 rescue by outsplicing of mutated exon 30 coding for the COL15 domain.
|
15009107 |
2004 |
Epidermolysis Bullosa
|
0.100 |
GeneticVariation
|
disease |
LHGDN |
A novel homozygous point mutation in the COL17A1 gene in a Chinese family with generalized atrophic benign epidermolysis bullosa.
|
11912005 |
2002 |
Epidermolysis Bullosa
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
These include mutations in the type VII collagen gene (COL7A1) in the dystrophic (severely scarring) forms of EB; mutations in the laminin 5 genes (LAMA3, LAMB3 and LAMC2) in a lethal (Herlitz) variant of junctional EB; aberrations in the type XVII collagen gene (COL17A1) in non-lethal forms of junctional EB; mutations in the alpha6 and beta4 integrin genes in a distinct hemidesmosomal variant of EB with congenital pyloric atresia; and mutations in the plectin gene (PLEC1) in a form of EB associated with late-onset muscular dystrophy.
|
10367729 |
1999 |
Epidermolysis Bullosa
|
0.100 |
Biomarker
|
disease |
BEFREE |
Indirect immunofluorescence was positive for monoclonal antibodies against type VII collagen, laminin 5, uncein, alpha6 and beta4 integrins, BPAG2, and HD1/plectin, which are known to be reduced or absent in specific subsets of severe EB.
|
9620484 |
1998 |
Epidermolysis Bullosa
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
These findings indicate that the absent expression of LAD-1 is observed in a BPAG2-deficient generalized atrophic benign epidermolysis bullosa patient with mutations in both alleles of COL17A1, and not in other epidermolysis bullosa subtypes.
|
9804354 |
1998 |
Epidermolysis Bullosa
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Implications of intragenic marker homozygosity and haplotype sharing in a rare autosomal recessive disorder: the example of the collagen type XVII (COL17A1) locus in generalised atrophic benign epidermolysis bullosa.
|
9254855 |
1997 |